I think "cure" is a little premature at this point, but as a treatment this is VERY VALUABLE. I'm looking forward to seeing how this evolves. If the trials are positive we could be looking at a Dendreon type run. I'm definitely LONG now.
New to the stock, bought some friday on the breakout.
anything alzheimer's makes people go crazy. the patent issues which may be very profitable only thorw gas on the fire. 5-6 could be here in a blink. If the study looks promosing in july, we will see a dndn type move no doubt.